Skip to main content
SpringerLink
Log in

Interactions

  • Chapter
Clinical Nuclear Medicine

  • 138 Accesses

Abstract

The diagnostic or therapeutic efficacy of a radiopharmaceutical is highly dependent on its bio-distribution within the body after administration. Unintended alteration of this biodistribution can lead to sub-optimal outcome of a nuclear medicine procedure. It is highly likely that most patients will be taking some form of medication, and the possible effects of these drugs on the biodistribution of radiopharmaceuticals need to be considered. Therefore, an awareness of the potentially important interactions between radiopharmaceuticals and drugs is important for nuclear medicine departments. Such knowledge can be used to prevent occurrence of potentially detrimental effects by modifying the patient’s drugs before the procedure, thereby reducing the possibility of alteration in radiopharmaceutical biodistribution.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Grayson, R.R. (1960) Factors which influence the radioactive iodine thyroidal uptake test. Am. J. Med., 28, 397–415.

    Article  PubMed  CAS  Google Scholar 

  2. Callahan, R.J. and Rabito, C.A. (1990) Radiolabelling of erythrocytes with technetium-99m: role of band-3 protein in the transport of pertechnetate across the cell membrane. J. Nucl. Med., 31, 2004–10.

    PubMed  CAS  Google Scholar 

  3. Hicks, R.J., Eu, P. and Arkles, L.B. (1992) Efficiency : of labelling red blood cells with technetium-99m after dipyridamole infusion for thallium stress testing. Eur. J. Nucl. Med., 19, 1050–3.

    Article  PubMed  CAS  Google Scholar 

  4. Hladik, W.B., Ponto, J.A., Lentle, B.C. and Laven, D.L. (1987) Iatrogenic alterations in the bio-distribution of radiotracers as a result of drug therapy: reported instances, in Essentials of Nuclear Medicine Science (eds W.B. Hladik and G.B. Saha), Williams and Wilkins, Baltimore, pp. 189–219.

    Google Scholar 

  5. Hesslewood, S. and Leung, E. (1994) Drug interaction with radiopharmaceuticals. Eur. J. Nucl. Med., 21, 348–56.

    Article  PubMed  CAS  Google Scholar 

  6. Sampson, C.B. and Cox, P.H. (1994) Effect of patient medication and other factors on the biodistribution of radiopharmaceuticals, in Textbook of Radio-pharmacy Theory and Practice (ed. C.B. Sampson), Gordon and Breach Science Publishers, pp. 215–27.

    Google Scholar 

  7. Hladik, W.B., Nigg, K.K. and Rhodes, B.A. (1982) Drug-induced changes in the biologic distribution of radiopharmaceuticals. Semin. Nucl. Med., 12, 184–210.

    Article  PubMed  CAS  Google Scholar 

  8. Leung, S.C.E. and Hesslewood, S.R. (1994) Use of drugs to enhance nuclear medicine studies, in Textbook of Radiopharmacy Theory and Practice (ed. C.B. Sampson), Gordon and Breach Science Publishers, pp. 225–41.

    Google Scholar 

  9. Pennell, D.J. (1994) Pharmacological cardiac stress: when and how ? Nucl. Med. Commun., 15, 578–85.

    Article  PubMed  CAS  Google Scholar 

  10. Smits, P., Corstens, F.H.M., Aengevaer, W.R.M. et al. (1991) False-negative dipyridamole thallium-201 myocardial imaging after caffeine infusion. J. Nucl. Med., 32, 1538–41.

    PubMed  CAS  Google Scholar 

  11. Jacobson, A.F., Cerqueria, M.D., Raisys, V. et al. (1994) Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine. Eur. J. Nucl. Med., 21, 23–6.

    PubMed  CAS  Google Scholar 

  12. Young, M., Pan, W., Wiesner, J. et al. (1994) Characterization of arbutamine: a novel catecholamine stress agent for diagnosis of coronary artery disease. Drug Dev. Res., 32, 19–28.

    Article  CAS  Google Scholar 

  13. Sandler, E.D., Parisi, M.T. and Hattner, R.S. (1991) Duration of etidronate effect demonstrated by serial bone scintigraphy. J. Nucl. Med., 32, 1782–4.

    PubMed  CAS  Google Scholar 

  14. Hommeyer, S.H., Varney, D.M. and Eary, J.F. (1992) Skeletal non-visualization in a bone scan secondary to intravenous etidronate therapy. J. Nucl. Med., 33, 748–50.

    PubMed  CAS  Google Scholar 

  15. Pecherstorfer, M., Schilling, T., Janisch, S. et al. (1993) Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer. J. Nucl. Med., 34,1039–44.

    PubMed  CAS  Google Scholar 

  16. Koyano, H., Schimizu, T. and Shishiba, Y. (1995) The biphosphonate dilemma. J. Nucl. Med., 36, 705.

    PubMed  CAS  Google Scholar 

  17. Solanki, K.K., Bomanji, J., Moves, J. et al. (1992) A pharmacological guide to medicines which interfere with the biodistribution of radiolabeled meta-iodobenzylguanidine (MIBG). Nucl. Med. Commun., 13, 513–21.

    Article  PubMed  CAS  Google Scholar 

  18. Mazière, B. and Mazière, M. (1990) Where have we got with neuroreceptor mapping of the human brain? Eur. J. Nucl. Med., 16, 817–35.

    Article  PubMed  Google Scholar 

  19. Verhoeff, N.P.L.G. (1991) Pharmacological implications for neuroreceptor imaging. Eur. J. Nucl. Med., 18, 482–502.

    Article  PubMed  CAS  Google Scholar 

  20. Kerwin, R.W. and Pilowsky, L.S. (1995) Traditional receptor theory and its application to neuroreceptor measurements in functional imaging. Eur. J. Nucl. Med., 22, 699–710.

    Article  PubMed  CAS  Google Scholar 

  21. Levin, J.M., Holman, B.L., Mendelson, J.H. et al (1994) Gender differences in cerebral perfusion in cocaine abuse: technetium 99m-HMPAO SPECT study of drug abusing women. J. Nucl. Med., 35, 1902–9.

    PubMed  CAS  Google Scholar 

  22. Levin, J.M., Mendelson, J.H., Holman, B. et al. (1995) Improved regional blood flow in chronic cocaine polydrug users treated with buprenorphine. J. Nucl. Med., 36, 1211–15.

    PubMed  CAS  Google Scholar 

  23. Srivastava, S.C. and Chervu, L.R. (1984) Radionuclide labeled red blood cells: current status and future prospects. Semin. Nucl. Med., 14, 68–82.

    Article  PubMed  CAS  Google Scholar 

  24. Millar, A.M., Wathen, C.G. and Muir, A.L. (1983) Failure in labelling of red blood cells with 99mTc: interaction between intravenous cannulae and stannous pyrophosphate. Eur. J. Nucl. Med., 8, 502–41.

    Article  PubMed  CAS  Google Scholar 

  25. Hambye, A.S., Vandermeiren, R., Vervaet, A. et al. (1995) Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations. Eur. J. Nucl. Med., 22, 61–67.

    Article  PubMed  CAS  Google Scholar 

  26. Eising, E.G. and Sciuk, J. (1995) Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations. Eur. J. Nucl. Med., 22, 587.

    Article  PubMed  CAS  Google Scholar 

  27. Chung, C.J., Hicklin, O.A., Payan, J.M. et al. (1991) Indium-Ill labelled leukocyte scan in detection of synthetic vascular graft infection: the effect of antibiotic treatment. J. Nucl. Med., 32, 13–15.

    PubMed  CAS  Google Scholar 

  28. Datz, F.L. and Thorne, D.A. (1986) Effect of antibiotic therapy on the sensitivity of indium-Ill labelled leukocyte scans. J. Nucl. Med., 27, 1849–53.

    PubMed  CAS  Google Scholar 

  29. Blake, G.M., Lewington, V.J., Fleming, J.S. et al. (1988) Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma. Eur. J. Nucl. Med., 14, 345–8.

    PubMed  CAS  Google Scholar 

  30. Koong, S.S., Movius, E.G., Keenan, A.M. et al. (1995) The effects of lithium in radioiodine therapy of metastatic well differentiated thyroid carcinoma. J. Nucl. Med., 36,15P.

    Google Scholar 

  31. Flynn, B.M. and Treves, S.T. (1987) Diffuse hepatic uptake of technetium-99m methylene dipho sphonate in a patient receiving high-dose methotrexate. J. Nucl. Med., 28, 532–4.

    PubMed  CAS  Google Scholar 

  32. Lutrin, C.L., McDougall, I.R. and Goris, M.I. (1978 Intense concentration of Tc-99m pyrophosphate ir the kidneys of children treated with chemo therapeutic drugs for malignant disease. Radiology 128, 165–7.

    PubMed  CAS  Google Scholar 

  33. Bekerman, C., Pavel, D.G., Bitran, U. et al. (1984) The effects of inadvertent administration of antineoplastic agents prior to Ga-67 injection: concise communication. J. Nucl. Med., 25, 430–35.

    PubMed  CAS  Google Scholar 

  34. Carrie, I., Estorch, M. and Löpez-Pousa, A. (1996 Assessing anthracycline cardiotoxicity in the 1990s Eur. J. Nucl. Med., 23, 359–64.

    Article  Google Scholar 

  35. Wang, T.S., Fawwaz, R.A., Esser, P.D. et al. (1978) Altered body distribution of Tc-99m pertechnetate in iatrogenic hyperaluminaemia. J. Nucl. Med., 19 381–3.

    PubMed  CAS  Google Scholar 

  36. Bobinet, D.D., Sevrin, R., Zurbriggen, M.T. et al (1974) Lung uptake of 99mTc-sulphur colloid in patient exhibiting presence of Al3+ in plasma. J. Nucl Med., 15, 1220–2.

    PubMed  CAS  Google Scholar 

  37. Zimmer, A.M. and Pavel, D.G. (1978) Expérimenta investigations of the possible cause of liver appearance during bone scanning. Radiology, 126, 813–16.

    PubMed  CAS  Google Scholar 

  38. Byun, H.H., Rodman, S.G. and Chung, K.E. (1976) Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex. J. Nucl. Med., 17, 374–5.

    PubMed  CAS  Google Scholar 

  39. Choy, D., Murray, I.P.C. and Hoschl, R. (1981) The effect of iron on the biodistribution of bone scanning agents in humans. Radiology, 140, 197–202.

    PubMed  CAS  Google Scholar 

Further Reading

  • Laven, D.L., Clanton, J.A., Hladik, W.B. and Shaw, S.M Pharmacological Alterations in the Bioroutingl Performance of Radiopharmaceuticals, Vols 1–4. Gammascar Consultants, Bay Pines, Florida 33504–4098, USA

    Google Scholar 

  • Swanson, D.P., Chilton, H.M. and Thrall, J.H. (1990) Pharmaceuticals in Medical Imaging. Macmillan Publishing Co., New York.

    Google Scholar 

Download references

Authors
  1. S. R. Hesslewood
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiological Sciences, Guy’s and St Thomas’ Hospital, London, UK

    M. N. Maisey BSc MD FRCR FRCP

  2. Department of Nuclear Medicine, St Bartholomew’s Hospital, London, UK

    K. E. Britton MD MSc FRCR FRCP

  3. Nuclear Medicine Department, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    B. D. Collier BA MA MD

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hesslewood, S.R. (1998). Interactions. In: Maisey, M.N., Britton, K.E., Collier, B.D. (eds) Clinical Nuclear Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3356-0_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-3356-0_46

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-75180-6

  • Online ISBN: 978-1-4899-3356-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation